IP Watch [15 October 2018]
“‘The People’s Prescription’: new report calls for value creation instead of value extraction in pharmaceutical R&D”
UCL News [15 October 2018]
“The health innovation system is ‘broken’ and failing patients”
Regulatory Affairs Professionals Society [24 September 2018]
“Researchers point to R&D treaty to spur new infectious disease treatments”
IP Watch [20 September 2018]
“WHO releases draft roadmap for access to medicines; comments show polarised views”
DNDi contribution to the World Health Organization roadmap on access to medicines and vaccines 2019-2023
10 September 2018
Geneva, Switzerland
As a contribution to the World Health Organization roadmap on access to medicines and vaccines, Dr Bernard Pécoul noted the importance of including concrete deliverables in the short-, medium-, and long-term, including prioritization of R&D, open and collaborative approaches to innovation, regulatory infrastructure, and solving gaps in diagnostics and specific needs of children.
DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Recife, Brazil – September 2018
DNDi and the Oswaldo Cruz Foundation, along with diverse national stakeholders, are partnering to improve access to diagnosis and treatment for Chagas disease in Brazil. The collaborative project was launched during the 54th Congress of the Brazilian Society of Tropical Medicine held in the city of Recife in northeast Brazil.
Frankfurter Rundschau [16 August 2018]
“Forschung auch für arme Patienten” – “Research also for poor patients”
Pharmaceutical Technology [24 July 2018]
“Curing hepatitis C at a fraction of the cost”
FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Amsterdam/Geneva – 23 July 2018
Initiative in Malaysia to enhance country’s public health approach to hepatitis C
FIND and the DNDi will partner to generate evidence that will support policy change and scale up of hepatitis C diagnosis and treatment. This work, announced at the AIDS 2018 conference in Amsterdam and ahead of World Hepatitis Day 2018, is being conducted in collaboration with the Ministry of Health in Malaysia with a view to overcoming barriers to diagnosis and treatment.
Le Monde [22 July 2018]
“L’hépatite C, la grande oubliée” – “Hepatitis C, the most overlooked”
Outbreak News Today [2 July 2018]
“Redefining access to medicines: panel Q&A from ISNTD d³ 2018”
Global Citizen [7 June 2018]
“How Switzerland is leading the fight against neglected tropical diseases”
DNDi and MMV, supported by Unitaid, deliver statement about R&D and access to child-friendly medicines at the 71st World Health Assembly
24 May 2018
Geneva, Switzerland
DNDi and MMV, supported by Unitaid, delivered a statement on the progress made by WHO in developing a Global Framework on Nurturing Care for Early Childhood Development. The statement calls for R&D and access to child-friendly medicines, and open data sharing of research findings.
HSB Noticias [6 May 2018]
“Crisis del ‘Chagas’ se agrava en Colombia según el Instituto Nacional de Salud” – “‘Chagas’ crisis worsens in Colombia according to the National Institute of Health”
MedTrop 2018
Congress of the Brazilian Society of Tropical Medicine
2-5 September 2018
Recife, Brazil
Posters on advances and challenges for Chagas disease and an access project in Colombia
DNDi participating in several round tables on Chagas disease and cutaneous leishmaniasis and the satellite forum FSBEIN
Forum Entwicklung
14 August 2018
Frankfurt, Germany
Graeme Bilbe – discussion on medical care in developing countries
Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind
by Grillon C, Krishtel PR, Mellouk O, Basenko A, Freeman J, Mendão L, Andrieux-Meyer I, and Morin S.
Journal of the International Aids Society, April 2018